Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of the American Heart Association
|
August 5, 2022
Adherence and Exercise Capacity Improvements of Patients With Adult Congenital Heart Disease Participating in Cardiac Rehabilitation
S Peter Sheng, Jodi L Feinberg, John A Bostrom, et al.
Toxicologic Pathology
|
March 14, 2018
Use of Severity Grades to Characterize Histopathologic Changes
Kenneth A Schafer, John Eighmy, James D Fikes, et al.
Toxicologic Pathology
|
October 8, 2010
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions
Michael W Leach, Wendy G Halpern, Carol W Johnson, et al.
Toxicologic Pathology
|
May 29, 2016
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development
Wendy G Halpern, Mehrdad Ameri, Christopher J Bowman, et al.
Pediatric Pulmonology
|
November 29, 2021
Surfactant protein D is a biomarker of influenza-related pediatric lung injury
Arindam Chakrabarti, Allen Nguyen, Margaret M Newhams, et al.
JACC. Advances
|
July 29, 2025
Impact of Adult Congenital Heart Disease Specialist Visits on Emergent Admissions: Evidence for Guidelines
Anushree Agarwal, Rong Duan, Joseph Bayne, et al.
American Heart Journal
|
August 9, 2025
Understanding gaps in guideline-recommended adult congenital heart disease care: Data from 12 US health care centers
Joseph Bayne, Rong Duan, Lindsey Rudov, et al.
Arthritis and Rheumatism
|
November 13, 2003
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
Kevin P Baker, Bryan M Edwards, Sarah H Main, et al.
Medical Care
|
January 8, 2026
The CHI-RON Study: Using PCORnet® and Patient Engagement Strategies to Improve Diversity Among Research Participants in the Congenital Heart Initiative
Anitha S John, Scott Leezer, Lindsey Rudov, et al.
JACC. Advances
|
June 28, 2024
COVID-19-Related Thrombotic and Bleeding Events in Adults With Congenital Heart Disease
Flavia Fusco, Richard A Krasuski, Soraya Sadeghi, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of the American Heart Association
|
August 5, 2022
Adherence and Exercise Capacity Improvements of Patients With Adult Congenital Heart Disease Participating in Cardiac Rehabilitation
S Peter Sheng, Jodi L Feinberg, John A Bostrom, et al.
Toxicologic Pathology
|
March 14, 2018
Use of Severity Grades to Characterize Histopathologic Changes
Kenneth A Schafer, John Eighmy, James D Fikes, et al.
Toxicologic Pathology
|
October 8, 2010
Use of tissue cross-reactivity studies in the development of antibody-based biopharmaceuticals: history, experience, methodology, and future directions
Michael W Leach, Wendy G Halpern, Carol W Johnson, et al.
Toxicologic Pathology
|
May 29, 2016
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development
Wendy G Halpern, Mehrdad Ameri, Christopher J Bowman, et al.
Pediatric Pulmonology
|
November 29, 2021
Surfactant protein D is a biomarker of influenza-related pediatric lung injury
Arindam Chakrabarti, Allen Nguyen, Margaret M Newhams, et al.
JACC. Advances
|
July 29, 2025
Impact of Adult Congenital Heart Disease Specialist Visits on Emergent Admissions: Evidence for Guidelines
Anushree Agarwal, Rong Duan, Joseph Bayne, et al.
American Heart Journal
|
August 9, 2025
Understanding gaps in guideline-recommended adult congenital heart disease care: Data from 12 US health care centers
Joseph Bayne, Rong Duan, Lindsey Rudov, et al.
Arthritis and Rheumatism
|
November 13, 2003
Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator
Kevin P Baker, Bryan M Edwards, Sarah H Main, et al.
Medical Care
|
January 8, 2026
The CHI-RON Study: Using PCORnet® and Patient Engagement Strategies to Improve Diversity Among Research Participants in the Congenital Heart Initiative
Anitha S John, Scott Leezer, Lindsey Rudov, et al.
JACC. Advances
|
June 28, 2024
COVID-19-Related Thrombotic and Bleeding Events in Adults With Congenital Heart Disease
Flavia Fusco, Richard A Krasuski, Soraya Sadeghi, et al.
Page
of 9